Pliant Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -26.7% | -81.9% | +27.9% | -83.7% | -100.0% | – | |
| – | – | – | – | – | +14.9% | -50.0% | +15.4% | -20.2% | |
| – | – | – | -26.7% | -81.9% | +27.9% | -83.7% | -234.5% | – | |
| – | +68.1% | +94.0% | +39.8% | +17.2% | +25.0% | +31.8% | +32.5% | -35.5% | |
| – | +70.0% | +68.2% | +58.0% | +59.6% | +45.0% | +45.0% | +1.9% | -20.0% | |
| – | +68.5% | +88.5% | +43.2% | -67.0% | +396.7% | +35.7% | +23.0% | -35.0% | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | +69.4% | -25.7% | +190.8% | +60.2% | +138.7% | -15.4% | |
| – | – | – | – | – | – | – | – | – | |
| – | -72.1% | -227.7% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.